I’m so happy to share the sixth episode of my What’s Next podcast, out today on @SpotifyUK , with director, writer, performer — and one of the UK's funniest women — @KathyBurke
I’m so happy to share the sixth episode of my What’s Next podcast, out today on @SpotifyUK , with director, writer, performer — and one of the UK's funniest women — @KathyBurke
@frodayss and @cancerplat are doing exceptional things both in advocacy of and driving innovation in #CancerResearch.
Listen to the inspirational @rickidove, a 12 year survivor of Triple Negative cancer diagnosis, on Nina's latest @Spotify podcast.
https://t.co/Z8S4QB2naT
"My cancer is incurable and any treatment offered is without curative intent." - @frodayss
We were honoured that Nina shared her story at last year’s #PinkRibbonBall.
Find out how you can support our Pink Ribbon Ball this year 👇
https://t.co/p9fujq7LYy
If you are looking for home insurance I DON’T recommend @TrinityClaims
I’ve had a claim with them since the beginning of the year and they are doing everything possible to be unhelpful.
"Without charities such as Breast Cancer Now that provide research and support for those effected by breast cancer I’m not sure that I would have seen my daughter turn 13!" - Nina
Thank you @frodayss for sharing your story and highlighting the importance of our work ❤️
Scientists from our Research Unit at @KingsCollegeLon have developed an AI model that can predict if triple negative breast cancer will spread.
They hope that one day this could help with treatment planning.
Thanks to funding support from @asda.
https://t.co/EcyUzT2D5f…
And I finally got to meet the gorgeous @frodayss Nina, who also has stage 4 Breast Cancer & works tirelessly to raise awareness of Triple Negative BC. We’ve been chatting online for over a year so it was great to finally meet face to face, alongside these other amazing ladies ❤️
@PTarantinoMD As a stage 4 TNBC patient, it makes me very happy to know there are more treatment options on the way. May they also continue to progress for metastatic TNBC
Early TNBC: a hard-to-treat disease in search for a biomarker. IO improved outcomes, ADCs may soon have a role. The more treatment options, the more opportunities for treatment tailoring. Thanks to @CancerNetwrk for inviting @hoperugo & me for this chat!
https://t.co/8ZzV82AWRF
Enhertu has recently been approved for pre-treated HER2-low metastatic (secondary) breast cancer in the EU and the USA. The approval is based on the phase 3 DESTINY-Breast04 trial which showed Enhertu increased the length of time before cancer got worse… https://t.co/0lfN893BFg
A small number of UK patients have received #Enhertu for HER2-low as part of a trial. We would love to hear from you if you have been on a trial.
We would also like to hear from you if you haven’t been on a trial but want to know more about HER2-low and Enhertu